295 related articles for article (PubMed ID: 32916306)
21. Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans.
Staley C; Khoruts A; Sadowsky MJ
Arch Med Res; 2017 Nov; 48(8):766-773. PubMed ID: 29183720
[TBL] [Abstract][Full Text] [Related]
22. Insights into the role of the microbiome in obesity and type 2 diabetes.
Hartstra AV; Bouter KE; Bäckhed F; Nieuwdorp M
Diabetes Care; 2015 Jan; 38(1):159-65. PubMed ID: 25538312
[TBL] [Abstract][Full Text] [Related]
23. Effects of Fecal Microbiome Transfer in Adolescents With Obesity: The Gut Bugs Randomized Controlled Trial.
Leong KSW; Jayasinghe TN; Wilson BC; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
JAMA Netw Open; 2020 Dec; 3(12):e2030415. PubMed ID: 33346848
[TBL] [Abstract][Full Text] [Related]
24. Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury.
Yang S; Hu T; Liu H; Lv YL; Zhang W; Li H; Xuan L; Gong LL; Liu LH
Biomed Pharmacother; 2021 Jun; 138():111441. PubMed ID: 33652261
[TBL] [Abstract][Full Text] [Related]
25. A Subset of Roux-en-Y Gastric Bypass Bacterial Consortium Colonizes the Gut of Nonsurgical Rats without Inducing Host-Microbe Metabolic Changes.
Liu Z; Coales I; Penney N; McDonald JAK; Phetcharaburanin J; Seyfried F; Li JV
mSystems; 2020 Dec; 5(6):. PubMed ID: 33293406
[TBL] [Abstract][Full Text] [Related]
26. Metabolic Responses to Butyrate Supplementation in LF- and HF-Fed Mice Are Cohort-Dependent and Associated with Changes in Composition and Function of the Gut Microbiota.
Lee S; Knotts TA; Goodson ML; Barboza M; Wudeck E; England G; Raybould HE
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33207675
[TBL] [Abstract][Full Text] [Related]
27. Distinct Fecal and Plasma Metabolites in Children with Autism Spectrum Disorders and Their Modulation after Microbiota Transfer Therapy.
Kang DW; Adams JB; Vargason T; Santiago M; Hahn J; Krajmalnik-Brown R
mSphere; 2020 Oct; 5(5):. PubMed ID: 33087514
[TBL] [Abstract][Full Text] [Related]
28. Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity.
Zhang XY; Chen J; Yi K; Peng L; Xie J; Gou X; Peng T; Tang L
Gut Microbes; 2020 Nov; 12(1):1-18. PubMed ID: 33222603
[TBL] [Abstract][Full Text] [Related]
29. Impact of fecal microbiota transplantation with capsules on the prevention of metabolic syndrome among patients with obesity.
Allegretti JR; Kassam Z; Hurtado J; Marchesi JR; Mullish BH; Chiang A; Thompson CC; Cummings BP
Hormones (Athens); 2021 Mar; 20(1):209-211. PubMed ID: 33420959
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy.
Kang Y; Cai Y
Hormones (Athens); 2017 Jul; 16(3):223-234. PubMed ID: 29278509
[TBL] [Abstract][Full Text] [Related]
31. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
[TBL] [Abstract][Full Text] [Related]
32. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome.
Xiao S; Fei N; Pang X; Shen J; Wang L; Zhang B; Zhang M; Zhang X; Zhang C; Li M; Sun L; Xue Z; Wang J; Feng J; Yan F; Zhao N; Liu J; Long W; Zhao L
FEMS Microbiol Ecol; 2014 Feb; 87(2):357-67. PubMed ID: 24117923
[TBL] [Abstract][Full Text] [Related]
33. Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review.
Zhang Z; Mocanu V; Cai C; Dang J; Slater L; Deehan EC; Walter J; Madsen KL
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31557953
[TBL] [Abstract][Full Text] [Related]
34. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents.
Leong KSW; Jayasinghe TN; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
BMJ Open; 2019 Apr; 9(4):e026174. PubMed ID: 31005929
[TBL] [Abstract][Full Text] [Related]
35. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
[TBL] [Abstract][Full Text] [Related]
36. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
37. The response to prolonged fasting in hypothalamic serotonin transporter availability is blunted in obesity.
van Galen KA; Booij J; Schrantee A; Adriaanse SM; Unmehopa UA; Fliers E; Schwartz GJ; DiLeone RJ; Ter Horst KW; la Fleur SE; Serlie MJ
Metabolism; 2021 Oct; 123():154839. PubMed ID: 34331964
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters.
Nam SB; Kim K; Kim BS; Im HJ; Lee SH; Kim SJ; Kim IJ; Pak K
Sci Rep; 2018 Mar; 8(1):4924. PubMed ID: 29563547
[TBL] [Abstract][Full Text] [Related]
39. Butyrate acts as a positive allosteric modulator of the 5-HT transporter to decrease availability of 5-HT in the ileum.
Cai J; Cheung J; Cheung SWM; Chin KTC; Leung RWK; Lam RST; Sharma R; Yiu JHC; Woo CW
Br J Pharmacol; 2024 Jun; 181(11):1654-1670. PubMed ID: 38129963
[TBL] [Abstract][Full Text] [Related]
40. Bletilla striata oligosaccharides improve metabolic syndrome through modulation of gut microbiota and intestinal metabolites in high fat diet-fed mice.
Hu B; Ye C; Leung EL; Zhu L; Hu H; Zhang Z; Zheng J; Liu H
Pharmacol Res; 2020 Sep; 159():104942. PubMed ID: 32504835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
